GENETIC-VIRAL-IMMUNOLOGIC STUDIES IN NEW ZEALAND MICE
新西兰小鼠的遗传病毒免疫学研究
基本信息
- 批准号:3169909
- 负责人:
- 金额:$ 30.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1979
- 资助国家:美国
- 起止时间:1979-07-01 至 1997-04-30
- 项目状态:已结题
- 来源:
- 关键词:B cell receptor B lymphocyte T cell receptor T lymphocyte anergy antinuclear autoantibody autoantibody autoimmune disorder clone cells disease /disorder model gene expression gene mutation genetically modified animals hybridomas immune tolerance /unresponsiveness immunogenetics immunoglobulin idiotypes immunoglobulin structure laboratory mouse leukocyte activation /transformation lymphoma molecular pathology neoplasm /cancer genetics northern blottings nucleic acid sequence oncogenes protein sequence synthetic peptide systemic lupus erythematosus tissue /cell culture
项目摘要
Our long-term goal is to define the fundamental mechanism of the systemic
autoimmune disease (SLE) and malignant B cell lymphomas that develop
spontaneously in the crosses between NZB and the normal SWR mouse strains.
The etiologic mechanism of Systemic lupus erythematosus (SLE) remains
elusive because the primary antigen that triggers the pathogenic autoimmune
response in this disease is unknown. In spite of this obstacle, we have
cloned the select T and B cells that are pathogenic in SLE. Analyses of
the structure and specificities of the receptors expressed by these
particular T and B cells that are representative of the disease and studies
of their regulation may lead to an understanding of the etiologic mechanism
of lupus. The major goals of this application involve:
1) Pathogenic B Cells: (a) Define the structural basis of cationic charge,
antigenic specificities, idiotypic cross reactions and clonal relationships
among pathogenic anti-DNA autoantibodies.
b) Study the germline V gene repertoire that generates the pathogenic
autoantibodies, define the natural specificities of antibodies encoded by
these germ line V genes and determine the degree of somatic mutations
required to generate the pathogenic autoantibodies.
c) Determine if the lupus-prone mice have an intrinsic B cell defect in
tolerance induction or in Ig somatic mutation mechanisms using transgenic
mice carrying autoantibody V genes.
2) Pathogenic T Cells: (a) Determine the V region sequences of the
receptors (TCRs) expressed by the pathogenic autoantibody-inducing T cells
to detect any clonal restriction/recurrent usage or any special feature in
their junctional region (CDR3) sequences that would provide clues for their
antigenic specificities.
b) Determine the specificities of these T helper cells that preferentially
interact with the pathogenic autoantibody-producing B cells, using
synthetic peptides and B-B hybridomas.
c) Attempt to block the pathogenic autoimmune response in vivo by
rendering the autoimmune T helper cells anergic.
These studies will help us to design specific therapies that could
intervene in the basic steps leading to systematic autoimmune disease in
lupus and may direct similar approaches for other rheumatic diseases where
the inciting antigen is unknown. Furthermore, understanding the nature of
the intrinsic B cell abnormally in these NZB crosses could help elucidate
the mechanism of B cell lymphoma development in these mice.
我们的长期目标是确定系统的基本机制,
自身免疫性疾病(SLE)和恶性B细胞淋巴瘤,
在NZB和正常SWR小鼠品系之间的杂交中自发地产生。
系统性红斑狼疮(SLE)的发病机制仍然是
因为引发致病性自身免疫的主要抗原
这种疾病的反应是未知的。 尽管有这个障碍,我们还是
克隆了在SLE中致病的选择性T和B细胞。 分析
这些受体表达的结构和特异性
特定的T和B细胞是疾病和研究的代表
它们的调节可能导致对病因机制的理解,
狼疮 该应用程序的主要目标包括:
1)致病性B细胞:(a)定义阳离子电荷的结构基础,
抗原特异性、独特型交叉反应和克隆关系
病原性抗DNA自身抗体
B)研究产生致病性病毒的生殖系V基因库。
自身抗体,定义抗体编码的天然特异性,
这些生殖系V基因并决定体细胞突变的程度
产生致病性自身抗体所必需的。
c)确定狼疮易感小鼠是否存在内在的B细胞缺陷
耐受性诱导或在IG体细胞突变机制中使用转基因
携带自身抗体V基因的小鼠。
2)病原性T细胞:(a)确定病原性T细胞的V区序列。
由致病性自身抗体诱导T细胞表达的TCR
检测任何克隆限制/复发使用或任何特殊功能,
它们的连接区(CDR3)序列,这将为它们的
抗原特异性
B)确定这些T辅助细胞的特异性,
与产生致病性自身抗体的B细胞相互作用,
合成肽和B-B杂交瘤。
c)试图通过以下方式阻断体内致病性自身免疫应答:
使自身免疫性T辅助细胞无反应性。
这些研究将帮助我们设计特定的治疗方法,
干预导致系统性自身免疫性疾病的基本步骤,
狼疮,并可能指导其他风湿性疾病的类似方法,
激发抗原未知。 此外,了解
这些NZ B杂交中固有B细胞异常有助于阐明
这些小鼠中B细胞淋巴瘤发展的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SYAMAL K DATTA其他文献
SYAMAL K DATTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SYAMAL K DATTA', 18)}}的其他基金
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
SLE 中 ANTICD40L 试验的免疫机制
- 批准号:
2882256 - 财政年份:1999
- 资助金额:
$ 30.45万 - 项目类别:
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
SLE 中 ANTICD40L 试验的免疫机制
- 批准号:
6137339 - 财政年份:1999
- 资助金额:
$ 30.45万 - 项目类别:
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
SLE 中 ANTICD40L 试验的免疫机制
- 批准号:
6341792 - 财政年份:1999
- 资助金额:
$ 30.45万 - 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
- 批准号:
2457949 - 财政年份:1993
- 资助金额:
$ 30.45万 - 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
- 批准号:
2748628 - 财政年份:1993
- 资助金额:
$ 30.45万 - 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
- 批准号:
6043194 - 财政年份:1993
- 资助金额:
$ 30.45万 - 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
- 批准号:
6374902 - 财政年份:1993
- 资助金额:
$ 30.45万 - 项目类别:
相似海外基金
Modulation of T-/B-lymphocyte immigration affects subsequent allograft damage (B06)
T/B 淋巴细胞迁移的调节会影响随后的同种异体移植物损伤 (B06)
- 批准号:
517500221 - 财政年份:2023
- 资助金额:
$ 30.45万 - 项目类别:
CRC/Transregios
development of therapeutic strategy for immune related adverse events by immune checkpoint inhivitor by focusing on B lymphocyte
以B淋巴细胞为重点,制定免疫检查点抑制剂免疫相关不良事件的治疗策略
- 批准号:
22K08541 - 财政年份:2022
- 资助金额:
$ 30.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Role and Regulation of Monocarboxylate Transporters 1 and 4 in Epstein-Barr Virus-mediated B Lymphocyte Tumorigenesis
单羧酸转运蛋白1和4在EB病毒介导的B淋巴细胞肿瘤发生中的作用和调节
- 批准号:
10154328 - 财政年份:2021
- 资助金额:
$ 30.45万 - 项目类别:
Dissecting Hem-1 functions in B lymphocyte Development and Primary Immunodeficiency Disease
剖析 Hem-1 在 B 淋巴细胞发育和原发性免疫缺陷病中的功能
- 批准号:
10385848 - 财政年份:2021
- 资助金额:
$ 30.45万 - 项目类别:
The role of Semaphorin 4C-PlexinB2 interaction in B-lymphocyte differentiation
Semaphorin 4C-PlexinB2 相互作用在 B 淋巴细胞分化中的作用
- 批准号:
RGPIN-2017-06735 - 财政年份:2021
- 资助金额:
$ 30.45万 - 项目类别:
Discovery Grants Program - Individual
The Role and Regulation of Monocarboxylate Transporters 1 and 4 in Epstein-Barr Virus-mediated B Lymphocyte Tumorigenesis
单羧酸转运蛋白1和4在EB病毒介导的B淋巴细胞肿瘤发生中的作用和调节
- 批准号:
10364632 - 财政年份:2021
- 资助金额:
$ 30.45万 - 项目类别:
Characterization of B Lymphocyte Deficiency in Pediatric Sickle Cell Disease
儿童镰状细胞病 B 淋巴细胞缺乏的特征
- 批准号:
10641800 - 财政年份:2020
- 资助金额:
$ 30.45万 - 项目类别:
Functional Consequences of Ubiquitin Depletion During B Lymphocyte Differentiation
B 淋巴细胞分化过程中泛素耗竭的功能后果
- 批准号:
10055003 - 财政年份:2020
- 资助金额:
$ 30.45万 - 项目类别:
Functional Consequences of Ubiquitin Depletion During B Lymphocyte Differentiation
B 淋巴细胞分化过程中泛素耗竭的功能后果
- 批准号:
10684125 - 财政年份:2020
- 资助金额:
$ 30.45万 - 项目类别:
Characterization of B Lymphocyte Deficiency in Pediatric Sickle Cell Disease
儿童镰状细胞病 B 淋巴细胞缺乏的特征
- 批准号:
10465088 - 财政年份:2020
- 资助金额:
$ 30.45万 - 项目类别: